HIV Vaccine Breakthroughs: Who Pays?

Anthony Canamucio In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals. --Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" be

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In and outside his territories and dominions ... and with his far off neighbors, Priyadarsi has arranged for the medical treatment of man and beast. He has caused herbs, roots and fruits to be imported, wells to be dug and trees to be planted on the roadside for the enjoyment of men and animals.

--Edits of Asoka, third century BC, inscribed on a rock in Girnar, Gujarat, India

On occasion, an ethical consensus may be reached only to unravel as the question of "who pays" becomes a reality. This is precisely the issue facing the sponsors of HIV vaccine clinical trials in developing countries concerning the treatment of vaccine breakthroughs--individuals who become infected after immunization because the vaccine failed to protect them.

Prior to the advent of potent antiretroviral therapy (ART), HIV vaccine trials offered an opportunity to study both the efficacy of an HIV vaccine and the potential to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Arthur Ammann

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development